Breakthrough Gene Therapy Offers Hope for Rare Genetic Epilepsy
Groundbreaking research from NUS Medicine reveals a promising gene therapy for a rare genetic form of epilepsy, targeting the KCNA2 gene mutation. This innovative approach uses Gapmer antisense oligonucleotides to reduce abnormal brain activity, offering hope for personalized treatments in epilepsy management. Discover how this advancement could transform the lives of patients with genetic epilepsy.
Groundbreaking Gene Therapy Treatment for Haemophilia B Introduced to NHS
Groundbreaking gene therapy treatment for haemophilia B has been introduced to the NHS, offering hope to patients like Elliott Collins. Elliott, who relied on regular injections for nearly three decades, has seen a significant improvement in his condition with the innovative therapy. This breakthrough in gene therapy provides new hope for individuals with haemophilia B, potentially offering an alternative to regular injections and improving their quality of life.
Pfizer’s Gene Therapy Setback Raises Concerns
Stay informed with the latest updates on market news, trade ideas, technical summaries, and economic calendars through XM Live Education. Learn about Pfizer’s setback in gene therapy development, German government’s supplementary budget plans, US lawmakers seeking China patent data, and more. Disclaimer: Information provided by XM Group entities is for educational purposes only and not financial advice.
Children born deaf gain hearing in both ears through gene therapy trial
Five children born deaf now have hearing in both ears after participating in a groundbreaking gene therapy trial conducted by doctors at Fudan University in Shanghai. The trial aimed to address inherited genetic mutations hindering the body’s ability to produce a crucial protein for transmitting auditory signals. After the treatment, the children exhibited improved hearing, could locate sound origins, and comprehend speech even in noisy environments. Dr. Zheng-Yi Chen expressed astonishment at the results, noting significant progress in the children’s hearing abilities.
Novel Gene Therapy Vehicle Successfully Crosses Blood-Brain Barrier in Mice
Researchers at the Broad Institute have developed a groundbreaking gene therapy delivery vehicle that effectively crosses the blood-brain barrier in mice, offering new possibilities for treating a range of brain diseases. This innovative approach utilizes a human protein to transport therapeutic genes into the brain, promising safer and more efficient treatments for neurodevelopmental and neurodegenerative disorders.
Baby girl born deaf hears unaided after groundbreaking gene therapy
Groundbreaking gene therapy enables baby girl born deaf to hear unaided for the first time. Opal Sandy from Oxfordshire received innovative gene therapy treatment at Addenbrooke’s Hospital in Cambridge, showing significant improvement in hearing within weeks. The therapy targeted the OTOF gene, responsible for producing otoferlin protein crucial for hearing. Results of treatment exceed expectations, offering hope for future advancements in treating hearing impairment.
Innovative Device Developed for Gene Therapy Delivery in Lung Diseases
Oregon State University researchers have developed a groundbreaking device for improving gene therapy in patients with inherited lung diseases like cystic fibrosis. The innovative microfluidic aerosolization platform aims to revolutionize gene therapy treatments by addressing the limitations of current nebulization techniques.
Tragic Incident in Pfizer’s Duchenne Muscular Dystrophy Trial
A tragic incident occurred in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, where a young boy lost his life. Despite attributing the cause of death to cardiac arrest, Pfizer is still investigating the incident to determine the exact circumstances surrounding the tragedy.
Experimental Gene Therapy Restores Vision in Patients with Inherited Blindness
An experimental gene therapy has shown promising results in restoring vision for patients with inherited blindness. College student Olivia Cook underwent a CRISPR-based gene-editing treatment that significantly improved her vision, providing hope for advancements in science and vision restoration. Despite being experimental, the therapy offers hope for treating inherited retinal disorders and combating blindness worldwide.
Revolutionary Gene Therapy Delivery Method Developed by UW–Madison Researchers
Discover the groundbreaking method developed by researchers at the University of Wisconsin–Madison to enhance the delivery of gene therapies through short electric pulses, increasing uptake by over 40 times. This innovative approach could lead to safer and more accessible treatments for genetic diseases like cystic fibrosis and diabetes.